Access
To read this article in full you may need to log in, make a payment or gain access through a site license (see right).
Nature Medicine 13, 6 (1 January 2007) | doi:10.1038/nm0107-6b;
Companies balk at California's patent rules for stem cell research
Abstract
California is set to adopt rules that will guarantee public return on its state-funded stem cell research, requiring grantees to share patented materials, send a portion of revenues to the state and guarantee cheap treatments to Californians. But the rules, which could set the tone for other state-funded science programs, are too restrictive and might put off companies, industry representatives warn.
To read this article in full you may need to log in, make a payment or gain access through a site license (see right).